,SpectrumID,X.Scan.,SpectrumFile,LibraryName,MQScore,TIC_Query,RT_Query,MZErrorPPM,SharedPeaks,MassDiff,SpecMZ,SpecCharge,FileScanUniqueID,NumberHits,Compound_Name,Ion_Source,Instrument,Compound_Source,PI,Data_Collector,Adduct,Precursor_MZ,ExactMass,Charge,CAS_Number,Pubmed_ID,Smiles,INCHI,INCHI_AUX,Library_Class,IonMode,Organism,LibMZ,UpdateWorkflowName,LibraryQualityString,tags,molecular_formula,InChIKey,InChIKey.Planar,superclass,class,subclass,npclassifier_superclass,npclassifier_class,npclassifier_pathway,library_usi,name_compound,name_parent_compound,chemical_source,pharmacologic_class,therapeutic_area,therapeutic_indication,mechanism_of_action,inchikey,smiles
1,CCMSLIB00000207289,12352,spectra_filtered.mgf,MASSBANK.mgf,0.983509,25360000,0,0,11,0,311.081,1,temp/spectra_filtered.mgf12352,1,"Massbank:EA018304 Sulfadimethoxine|4-amino-N-(2,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide",ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,311.081,0,1,122-11-2,N/A,c1(NS(c2ccc(N)cc2)(=O)=O)cc(nc(n1)OC)OC,"1S/C12H14N4O4S/c1-19-11-7-10(14-12(15-11)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H,14,15,16)",N/A,3,Positive,MASSBANK,311.081,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C12H14N4O4S,ZZORFUFYDOWNEF-UHFFFAOYSA-N,ZZORFUFYDOWNEF,Benzenoids,Benzene and substituted derivatives,Benzenesulfonamides,,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000207289,sulfadimethoxine,sulfadimethoxine,Medical|Background/QAQC,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,ZZORFUFYDOWNEF-UHFFFAOYSA-N,COc1cc(=NS(=O)(=O)c2ccc(N)cc2)[nH]c(OC)n1
2,CCMSLIB00000207393,9430,spectra_filtered.mgf,MASSBANK.mgf,0.953436,182090000,0,1.22275,3,0.000289917,237.102,1,temp/spectra_filtered.mgf9430,1,"Massbank:EA019410 Carbamazepine|5H-Dibenz[b,f]azepine-5-carboxamide|11-benzo[b][1]benzazepinecarboxamide",ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,237.102,0,1,298-46-4,N/A,N1(c2c(cccc2)C=Cc2c1cccc2)C(N)=O,"1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)",N/A,3,Positive,MASSBANK,237.102,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C15H12N2O,FFGPTBGBLSHEPO-UHFFFAOYSA-N,FFGPTBGBLSHEPO,Organoheterocyclic compounds,Benzazepines,Dibenzazepines,Anthranilic acid alkaloids,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000207393,carbamazepine,carbamazepine,Medical,mood stabilizer,neurology/psychiatry,seizures|trigeminal neuralgia,carboxamide antiepileptic,FFGPTBGBLSHEPO-UHFFFAOYSA-N,NC(=O)N1c2ccccc2C=Cc2ccccc21
3,CCMSLIB00000207429,3159,spectra_filtered.mgf,MASSBANK.mgf,0.97614,528400000,0,1.24147,5,0.000213623,172.072,1,temp/spectra_filtered.mgf3159,1,Massbank:EA019704 Metronidazole|2-Methyl-5-nitroimidazole-1-ethanol|2-(2-methyl-5-nitro-1-imidazolyl)ethanol,ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,172.072,0,1,443-48-1,N/A,CC1=NC=C(N1CCO)[N+]([O-])=O,"1S/C6H9N3O3/c1-5-7-4-6(9(11)12)8(5)2-3-10/h4,10H,2-3H2,1H3",N/A,3,Positive,MASSBANK,172.072,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,VAOCPAMSLUNLGC-UHFFFAOYSA-N,VAOCPAMSLUNLGC,Organoheterocyclic compounds,Azoles,Imidazoles,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000207429,metronidazole,metronidazole,Medical,nitroimidazole antimicrobial,infectious disease|dermatology,gram-positive bacterial infections|gram-negative bacterial infections,DNA inhibitor,VAOCPAMSLUNLGC-UHFFFAOYSA-N,Cc1ncc([N+](=O)[O-])n1CCO
4,CCMSLIB00000208374,7507,spectra_filtered.mgf,MASSBANK.mgf,0.988783,174270000,0,0.695589,10,0.000213623,307.111,1,temp/spectra_filtered.mgf7507,1,"Massbank:EA032804 Fluconazole|2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)-2-propanol",ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,307.111,0,1,86386-73-4,N/A,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3,"1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2",N/A,3,Positive,MASSBANK,307.111,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C13H12F2N6O,RFHAOTPXVQNOHP-UHFFFAOYSA-N,RFHAOTPXVQNOHP,Benzenoids,Benzene and substituted derivatives,Halobenzenes,,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000208374,fluconazole,fluconazole,Medical,azole antifungal,infectious disease,candidiasis|esophageal candidiasis|vaginal candidiasis|cryptococcal meningitis,sterol demethylase inhibitor,RFHAOTPXVQNOHP-UHFFFAOYSA-N,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F
5,CCMSLIB00000208971,4014,spectra_filtered.mgf,MASSBANK.mgf,0.980744,352500000,0,1.8209,12,0.000488281,268.154,1,temp/spectra_filtered.mgf4014,1,Massbank:EA069704 Atenolol acid|Metoprolol acid|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetic acid,ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,268.154,0,1,56392-14-4,N/A,CC(C)NCC(O)COc1ccc(cc1)CC(=O)O,"1S/C14H21NO4/c1-10(2)15-8-12(16)9-19-13-5-3-11(4-6-13)7-14(17)18/h3-6,10,12,15-16H,7-9H2,1-2H3,(H,17,18)",N/A,3,Positive,MASSBANK,268.154,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C14H21NO4,PUQIRTNPJRFRCZ-UHFFFAOYSA-N,PUQIRTNPJRFRCZ,N/A,N/A,N/A,Pseudoalkaloids,Phenylalanine-derived alkaloids,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000208971,metoprolol acid,atenolol|metoprolol,Drug metabolite,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|myocardial infarction,adrenergic receptor antagonist,PUQIRTNPJRFRCZ-UHFFFAOYSA-N,CC(C)NCC(O)COc1ccc(CC(=O)O)cc1
6,CCMSLIB00000208971,4014,spectra_filtered.mgf,MASSBANK.mgf,0.980744,352500000,0,1.8209,12,0.000488281,268.154,1,temp/spectra_filtered.mgf4014,1,Massbank:EA069704 Atenolol acid|Metoprolol acid|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetic acid,ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,268.154,0,1,56392-14-4,N/A,CC(C)NCC(O)COc1ccc(cc1)CC(=O)O,"1S/C14H21NO4/c1-10(2)15-8-12(16)9-19-13-5-3-11(4-6-13)7-14(17)18/h3-6,10,12,15-16H,7-9H2,1-2H3,(H,17,18)",N/A,3,Positive,MASSBANK,268.154,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C14H21NO4,PUQIRTNPJRFRCZ-UHFFFAOYSA-N,PUQIRTNPJRFRCZ,N/A,N/A,N/A,Pseudoalkaloids,Phenylalanine-derived alkaloids,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000208971,metoprolol acid,atenolol|metoprolol,Drug metabolite,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|myocardial infarction,adrenergic receptor antagonist,PUQIRTNPJRFRCZ-UHFFFAOYSA-N,CC(C)NCC(O)COc1ccc(CC(=O)O)cc1
7,CCMSLIB00000209382,7474,spectra_filtered.mgf,MASSBANK.mgf,0.862919,24590000,0,0.462044,6,0.00012207,264.196,1,temp/spectra_filtered.mgf7474,1,Massbank:EA103410 N-Desmethylvenlafaxine|1-[1-(4-methoxyphenyl)-2-(methylamino)ethyl]-1-cyclohexanol,ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,264.196,0,1,149289-30-5,N/A,CNCC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,"1S/C16H25NO2/c1-17-12-15(16(18)10-4-3-5-11-16)13-6-8-14(19-2)9-7-13/h6-9,15,17-18H,3-5,10-12H2,1-2H3",N/A,3,Positive,MASSBANK,264.196,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C16H25NO2,MKAFOJAJJMUXLW-UHFFFAOYSA-N,MKAFOJAJJMUXLW,N/A,N/A,N/A,,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000209382,n-desmethylvenlafaxine,venlafaxine,Drug metabolite,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MKAFOJAJJMUXLW-UHFFFAOYSA-N,CNCC(c1ccc(OC)cc1)C1(O)CCCCC1
8,CCMSLIB00000209983,8780,spectra_filtered.mgf,MASSBANK.mgf,0.829446,131300000,0,1.36236,11,0.000396729,291.207,1,temp/spectra_filtered.mgf8780,1,"Massbank:EA263710 D617|Verapamil metabolite D617|2-(3,4-dimethoxyphenyl)-2-isopropyl-5-(methylamino)valeronitrile",ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,291.207,0,1,34245-14-2,N/A,CC(C)C(CCCNC)(C#N)C1=CC(=C(C=C1)OC)OC,"1S/C17H26N2O2/c1-13(2)17(12-18,9-6-10-19-3)14-7-8-15(20-4)16(11-14)21-5/h7-8,11,13,19H,6,9-10H2,1-5H3",N/A,3,Positive,MASSBANK,291.207,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,WLOBUUJURNEQCL-UHFFFAOYSA-N,WLOBUUJURNEQCL,Benzenoids,Benzene and substituted derivatives,Phenylbutylamines,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000209983,d-617 (verapamil metabolite),verapamil,Drug metabolite,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris|arrhythmia,calcium channel blocker,WLOBUUJURNEQCL-UHFFFAOYSA-N,CNCCCC(C#N)(c1ccc(OC)c(OC)c1)C(C)C
9,CCMSLIB00000210200,5764,spectra_filtered.mgf,MASSBANK.mgf,0.951539,37770000,0,0.715214,9,0.000183105,256.015,1,temp/spectra_filtered.mgf5764,1,"Massbank:EA267604 Lamotrigine|6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine",ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,256.015,0,1,84057-84-1,N/A,Cl-c(ccc1)c(Cl)c1-c(nnc2N)c(n2)N,"1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)",N/A,3,Positive,MASSBANK,256.015,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C9H7Cl2N5,PYZRQGJRPPTADH-UHFFFAOYSA-N,PYZRQGJRPPTADH,Benzenoids,Benzene and substituted derivatives,Halobenzenes,,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000210200,lamotrigine,lamotrigine,Medical,antiepileptic drug (AED)|mood stabilizer,neurology/psychiatry,epilepsy|bipolar disorder,serotonin receptor antagonist|sodium channel blocker,PYZRQGJRPPTADH-UHFFFAOYSA-N,N=c1[nH]nc(-c2cccc(Cl)c2Cl)c(=N)[nH]1
10,CCMSLIB00000565063,20093,spectra_filtered.mgf,MONA.mgf,0.842045,111050000,0,2.37462,3,0.000396729,167.07,1,temp/spectra_filtered.mgf20093,1,MoNA:2745244 Napagin a,LC-ESI-ITFT,LC-ESI-ITFT,isolated,MoNA,MoNA,[M+H]+,167.07,0,1,N/A,N/A,CCOC(=O)c1ccc(O)cc1,"InChI=1S/C9H10O3/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6,10H,2H2,1H3",N/A,3,,MONA,167.07,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C9H10O3,NUVBSKCKDOMJSU-UHFFFAOYSA-N,NUVBSKCKDOMJSU,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Phenolic acids (C6-C1),Shikimic acids and derivatives|Simple phenolic acids,Shikimates and Phenylpropanoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000565063,ethyl hydroxybenzoate,ethyl hydroxybenzoate,Food|Medical,no_match,NA,NA,preservative,NUVBSKCKDOMJSU-UHFFFAOYSA-N,CCOC(=O)c1ccc(O)cc1
11,CCMSLIB00000841613,15314,spectra_filtered.mgf,MASSBANKEU.mgf,0.983971,1269900000,0,1.03241,6,0.000198364,192.138,1,temp/spectra_filtered.mgf15314,1,"MassbankEU:SM822301 DEET|N,N-diethyl-3-methylbenzamide",ESI,LC-ESI-QFT,Isolated,Massbank EU,Massbank,[M+H]+,192.138,0,1,134-62-3,N/A,CCN(CC)C(=O)C1=CC(C)=CC=C1,"1S/C12H17NO/c1-4-13(5-2)12(14)11-8-6-7-10(3)9-11/h6-9H,4-5H2,1-3H3",N/A,3,Positive,MASSBANKEU,192.138,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C12H17NO,MMOXZBCLCQITDF-UHFFFAOYSA-N,MMOXZBCLCQITDF,Benzenoids,Benzene and substituted derivatives,Toluenes,,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000841613,diethyltoluamide,diethyltoluamide,Medical|Personal Care,other insecticides and repellents,NA,NA,ionotropic receptor IR40a activator,MMOXZBCLCQITDF-UHFFFAOYSA-N,CCN(CC)C(=O)c1cccc(C)c1
12,CCMSLIB00003135294,8662,spectra_filtered.mgf,GNPS-NIST14-MATCHES.mgf,0.895443,4.65e+08,0,2.94294,6,0.00050354,171.102,1,temp/spectra_filtered.mgf8662,1,Spectral Match to Azelaic acid from NIST14,ESI,qTof,Isolated,Data from Christopher A. Lowry,Data deposited by fevargas,M+H-H2O,171.101,188.105,1,123999,N/A,C(CCCC(=O)O)CCCC(=O)O,"InChI=1S/C9H16O4/c10-8(11)6-4-2-1-3-5-7-9(12)13/h1-7H2,(H,10,11)(H,12,13)",N/A,3,Positive,GNPS-NIST14-MATCHES,171.101,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C9H16O4,BDJRBEYXGGNYIS-UHFFFAOYSA-N,BDJRBEYXGGNYIS,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Fatty Acids and Conjugates,Dicarboxylic acids,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003135294,azelaic acid,azelaic acid,Endogenous|Food|Medical|Personal Care,other anti-acne preparations for topical use,dermatology,rosacea|acne,tyrosinase inhibitor,BDJRBEYXGGNYIS-UHFFFAOYSA-N,O=C(O)CCCCCCCC(=O)O
13,CCMSLIB00003135725,8723,spectra_filtered.mgf,GNPS-NIST14-MATCHES.mgf,0.707557,6.9e+07,0,17.0097,8,0.00488281,287.055,1,temp/spectra_filtered.mgf8723,1,"Spectral Match to 3,5,7,3',4'-Pentahydroxyflavanone from NIST14",ESI,qTof,Isolated,Data from Wolfender/Litaudon,Data deposited by pmallard,M+H-H2O,287.06,304.058,1,480182,N/A,C1=CC(=C(C=C1[C@@H]2[C@H](C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,"InChI=1S/C15H12O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,14-19,21H/t14-,15+/m0/s1",N/A,3,Positive,GNPS-NIST14-MATCHES,287.06,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C15H12O7,CXQWRCVTCMQVQX-LSDHHAIUSA-N,CXQWRCVTCMQVQX,Phenylpropanoids and polyketides,Flavonoids,Flavans,Flavonoids,Dihydroflavonols,Shikimates and Phenylpropanoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003135725,cianidanol,cianidanol,Food|Medical,no_match,NA,NA,opioid receptor antagonist,CXQWRCVTCMQVQX-LSDHHAIUSA-N,O=C1C(O)c2c(O)cc(O)cc2OC1c1ccc(O)c(O)c1
14,CCMSLIB00003136961,33896,spectra_filtered.mgf,GNPS-NIST14-MATCHES.mgf,0.801617,57480000,0,2.05634,6,0.000915527,445.223,1,temp/spectra_filtered.mgf33896,1,Spectral Match to Dioctyl sulfosuccinate from NIST14,ESI,QqQ,Isolated,Data from Lihini Aluwihare,Data deposited by daniel,M+Na,445.222,0,1,10041197,N/A,N/A,N/A,N/A,3,Positive,GNPS-NIST14-MATCHES,445.222,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003136961,docusate sodium,docusate sodium,Medical,"softeners, emollients",gastroenterology,constipation,laxative,HNSDLXPSAYFUHK-UHFFFAOYSA-N,CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)O
15,CCMSLIB00003138920,20927,spectra_filtered.mgf,GNPS-NIST14-MATCHES.mgf,0.84774,271100000,0,21.9494,6,0.00379944,173.096,1,temp/spectra_filtered.mgf20927,1,Spectral Match to Formestane from NIST14,ESI,IT/ion trap,Isolated,Data from Wolfender/Litaudon,Data deposited by pmallard,173.1,173.1,0,1,566483,N/A,N/A,N/A,N/A,3,Positive,GNPS-NIST14-MATCHES,173.1,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003138920,formestane,formestane,Medical,aromatase inhibitors,oncology,breast cancer,aromatase inhibitor,N/A,N/A
16,CCMSLIB00003139980,10110,spectra_filtered.mgf,GNPS-NIST14-MATCHES.mgf,0.775962,283900000,0,0.609961,5,0.000106812,175.112,1,temp/spectra_filtered.mgf10110,1,Spectral Match to (-)-Perillyl alcohol from NIST14,ESI,QqQ,Isolated,Data from Wolfender/Litaudon,Data deposited by pmallard,M+Na,175.112,0,1,18457551,N/A,N/A,N/A,N/A,3,Positive,GNPS-NIST14-MATCHES,175.112,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003139980,perillyl alcohol,perillyl alcohol,Food|Medical,no_match,NA,NA,apoptosis stimulant|farnesyltransferase inhibitor,NDTYTMIUWGWIMO-SNVBAGLBSA-N,C=C(C)C1CC=C(CO)CC1
17,CCMSLIB00003139980,18213,spectra_filtered.mgf,GNPS-NIST14-MATCHES.mgf,0.786768,177700000,0,0.609961,5,0.000106812,175.112,1,temp/spectra_filtered.mgf18213,1,Spectral Match to (-)-Perillyl alcohol from NIST14,ESI,QqQ,Isolated,Data from Wolfender/Litaudon,Data deposited by pmallard,M+Na,175.112,0,1,18457551,N/A,N/A,N/A,N/A,3,Positive,GNPS-NIST14-MATCHES,175.112,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003139980,perillyl alcohol,perillyl alcohol,Food|Medical,no_match,NA,NA,apoptosis stimulant|farnesyltransferase inhibitor,NDTYTMIUWGWIMO-SNVBAGLBSA-N,C=C(C)C1CC=C(CO)CC1
18,CCMSLIB00004695483,42703,spectra_filtered.mgf,MONA.mgf,0.728124,87380000,0,14.6526,6,0.00640869,437.381,1,temp/spectra_filtered.mgf42703,1,gamma-sitosterol,N/A,ESI-QFT,isolated,MoNA,MoNA:VF-NPL-QEHF004420,[M+Na]+,437.375,0,1,N/A,N/A,CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(C)C,"InChI=1S/C29H50O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h10,19-21,23-27,30H,7-9,11-18H2,1-6H3/t20-,21-,23+,24+,25-,26+,27+,28+,29-/m1/s1",N/A,3,positive,MONA,437.375,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C29H50O,KZJWDPNRJALLNS-VJSFXXLFSA-N,KZJWDPNRJALLNS,Lipids and lipid-like molecules,Steroids and steroid derivatives,Stigmastanes and derivatives,Steroids,Stigmastane steroids,Terpenoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00004695483,sitosterol,sitosterol,Food|Medical,no_match,NA,NA,NA,KZJWDPNRJALLNS-FBZNIEFRSA-N,CCC(CCC(C)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C
19,CCMSLIB00004695483,42126,spectra_filtered.mgf,MONA.mgf,0.701719,68110000,0,14.6526,6,0.00640869,437.381,1,temp/spectra_filtered.mgf42126,1,gamma-sitosterol,N/A,ESI-QFT,isolated,MoNA,MoNA:VF-NPL-QEHF004420,[M+Na]+,437.375,0,1,N/A,N/A,CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(C)C,"InChI=1S/C29H50O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h10,19-21,23-27,30H,7-9,11-18H2,1-6H3/t20-,21-,23+,24+,25-,26+,27+,28+,29-/m1/s1",N/A,3,positive,MONA,437.375,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C29H50O,KZJWDPNRJALLNS-VJSFXXLFSA-N,KZJWDPNRJALLNS,Lipids and lipid-like molecules,Steroids and steroid derivatives,Stigmastanes and derivatives,Steroids,Stigmastane steroids,Terpenoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00004695483,sitosterol,sitosterol,Food|Medical,no_match,NA,NA,NA,KZJWDPNRJALLNS-FBZNIEFRSA-N,CCC(CCC(C)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C
20,CCMSLIB00005434451,7369,spectra_filtered.mgf,GNPS-LIBRARY.mgf,0.962784,57440000,0,0.244298,8,0.000183105,749.516,1,temp/spectra_filtered.mgf7369,1,Azithromycin - Dark Web Drugs,ESI,Orbitrap,Other,Dorrestein,A. Lu,M+H,749.516,0,1,83905-01-05,N/A,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,"InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1",N/A,3,Positive,GNPS-LIBRARY,749.516,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C38H72N2O12,MQTOSJVFKKJCRP-UHFFFAOYSA-N,MQTOSJVFKKJCRP,Organic oxygen compounds,Organooxygen compounds,Carbohydrates and carbohydrate conjugates,Macrolides,Erythromycins,Polyketides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005434451,azithromycin,azithromycin,Medical,macrolide antimicrobial,infectious disease,pelvic inflammatory disease|pneumonia|urethritis|cervicitis|sinusitis,bacterial 50S ribosomal subunit inhibitor,MQTOSJVFKKJCRP-BICOPXKESA-N,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)CN(C)C(C)C(O)C1(C)O
21,CCMSLIB00005435779,2536,spectra_filtered.mgf,GNPS-LIBRARY.mgf,0.979669,612640000,0,3.12363,10,0.000915527,293.098,1,temp/spectra_filtered.mgf2536,1,Ethylenediaminetetraacetic acid EDTA,LC-ESI,qTof,Crude,Dorrestein,lfnothias,M+H,293.097,0,1, , ,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)", ,3,Positive,GNPS-LIBRARY,293.097,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H16N2O8,KCXVZYZYPLLWCC-UHFFFAOYSA-N,KCXVZYZYPLLWCC,Organic acids and derivatives,Carboxylic acids and derivatives,Tetracarboxylic acids and derivatives,Small peptides,Aminoacids,Amino acids and Peptides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435779,edta ,edta ,Background/QAQC,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
22,CCMSLIB00005435779,1538,spectra_filtered.mgf,GNPS-LIBRARY.mgf,0.973828,548500000,0,2.39478,9,0.000701904,293.098,1,temp/spectra_filtered.mgf1538,1,Ethylenediaminetetraacetic acid EDTA,LC-ESI,qTof,Crude,Dorrestein,lfnothias,M+H,293.097,0,1, , ,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)", ,3,Positive,GNPS-LIBRARY,293.097,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H16N2O8,KCXVZYZYPLLWCC-UHFFFAOYSA-N,KCXVZYZYPLLWCC,Organic acids and derivatives,Carboxylic acids and derivatives,Tetracarboxylic acids and derivatives,Small peptides,Aminoacids,Amino acids and Peptides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435779,edta ,edta ,Background/QAQC,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
23,CCMSLIB00005435779,1283,spectra_filtered.mgf,GNPS-LIBRARY.mgf,0.974572,572160000,0,2.08242,9,0.000610352,293.098,1,temp/spectra_filtered.mgf1283,1,Ethylenediaminetetraacetic acid EDTA,LC-ESI,qTof,Crude,Dorrestein,lfnothias,M+H,293.097,0,1, , ,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)", ,3,Positive,GNPS-LIBRARY,293.097,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H16N2O8,KCXVZYZYPLLWCC-UHFFFAOYSA-N,KCXVZYZYPLLWCC,Organic acids and derivatives,Carboxylic acids and derivatives,Tetracarboxylic acids and derivatives,Small peptides,Aminoacids,Amino acids and Peptides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435779,edta ,edta ,Background/QAQC,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
24,CCMSLIB00005435780,1783,spectra_filtered.mgf,GNPS-LIBRARY.mgf,0.957759,41410000,0,2.22771,10,0.000701904,315.08,1,temp/spectra_filtered.mgf1783,1,Ethylenediaminetetraacetic acid EDTA,LC-ESI,qTof,Crude,Dorrestein, ,M+Na,315.079,0,1, , ,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)", ,3,Positive,GNPS-LIBRARY,315.079,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H16N2O8,KCXVZYZYPLLWCC-UHFFFAOYSA-N,KCXVZYZYPLLWCC,Organic acids and derivatives,Carboxylic acids and derivatives,Tetracarboxylic acids and derivatives,Small peptides,Aminoacids,Amino acids and Peptides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435780,edta ,edta ,Background/QAQC,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
25,CCMSLIB00005435780,977,spectra_filtered.mgf,GNPS-LIBRARY.mgf,0.948997,40880000,0,1.54971,10,0.000488281,315.079,1,temp/spectra_filtered.mgf977,1,Ethylenediaminetetraacetic acid EDTA,LC-ESI,qTof,Crude,Dorrestein, ,M+Na,315.079,0,1, , ,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)", ,3,Positive,GNPS-LIBRARY,315.079,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H16N2O8,KCXVZYZYPLLWCC-UHFFFAOYSA-N,KCXVZYZYPLLWCC,Organic acids and derivatives,Carboxylic acids and derivatives,Tetracarboxylic acids and derivatives,Small peptides,Aminoacids,Amino acids and Peptides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435780,edta ,edta ,Background/QAQC,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
26,CCMSLIB00005435780,2456,spectra_filtered.mgf,GNPS-LIBRARY.mgf,0.941482,50520000,0,2.51828,11,0.000793457,315.08,1,temp/spectra_filtered.mgf2456,1,Ethylenediaminetetraacetic acid EDTA,LC-ESI,qTof,Crude,Dorrestein, ,M+Na,315.079,0,1, , ,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)", ,3,Positive,GNPS-LIBRARY,315.079,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H16N2O8,KCXVZYZYPLLWCC-UHFFFAOYSA-N,KCXVZYZYPLLWCC,Organic acids and derivatives,Carboxylic acids and derivatives,Tetracarboxylic acids and derivatives,Small peptides,Aminoacids,Amino acids and Peptides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435780,edta ,edta ,Background/QAQC,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
27,CCMSLIB00005435780,1444,spectra_filtered.mgf,GNPS-LIBRARY.mgf,0.944173,60150000,0,1.84028,10,0.000579834,315.08,1,temp/spectra_filtered.mgf1444,1,Ethylenediaminetetraacetic acid EDTA,LC-ESI,qTof,Crude,Dorrestein, ,M+Na,315.079,0,1, , ,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)", ,3,Positive,GNPS-LIBRARY,315.079,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H16N2O8,KCXVZYZYPLLWCC-UHFFFAOYSA-N,KCXVZYZYPLLWCC,N/A,N/A,N/A,Small peptides,Aminoacids,Amino acids and Peptides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435780,edta ,edta ,Background/QAQC,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
28,CCMSLIB00005435780,1188,spectra_filtered.mgf,GNPS-LIBRARY.mgf,0.958115,46120000,0,1.84028,12,0.000579834,315.08,1,temp/spectra_filtered.mgf1188,1,Ethylenediaminetetraacetic acid EDTA,LC-ESI,qTof,Crude,Dorrestein, ,M+Na,315.079,0,1, , ,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)", ,3,Positive,GNPS-LIBRARY,315.079,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H16N2O8,KCXVZYZYPLLWCC-UHFFFAOYSA-N,KCXVZYZYPLLWCC,Organic acids and derivatives,Carboxylic acids and derivatives,Tetracarboxylic acids and derivatives,Small peptides,Aminoacids,Amino acids and Peptides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435780,edta ,edta ,Background/QAQC,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
29,CCMSLIB00005435812,5287,spectra_filtered.mgf,GNPS-LIBRARY.mgf,0.870389,1.9e+08,0,24.0903,2,0.00469971,195.092,1,temp/spectra_filtered.mgf5287,1,Caffeine,LC-ESI,qTof,Isolated,Le Pogam,Turpin,M+H,195.087,194.08,1,95789-13-2, ,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,"1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3", ,3,Positive,GNPS-LIBRARY,195.087,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,Food:Other[Sample Type Detected],C8H10N4O2,RYYVLZVUVIJVGH-UHFFFAOYSA-N,RYYVLZVUVIJVGH,Organoheterocyclic compounds,Imidazopyrimidines,Purines and purine derivatives,Pseudoalkaloids,Purine alkaloids,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435812,caffeine,caffeine,Food|Medical,central nervous system stimulant|methylxanthine,neurology/psychiatry|pulmonary,fatigue|drowsiness|apné,adenosine receptor antagonist|phosphodiesterase inhibitor,RYYVLZVUVIJVGH-UHFFFAOYSA-N,Cn1c(=O)c2c(ncn2C)n(C)c1=O
30,CCMSLIB00005464401,344,spectra_filtered.mgf,GNPS-MSMLS.mgf,0.832709,13830000,0,36.7603,5,0.00790405,215.008,1,temp/spectra_filtered.mgf344,1,CITRATE,ESI,Orbitrap,Commercial,Dorrestein,Kelly Weldon,M+Na,215.016,192.027,1,77-92-9,N/A,OC(=O)CC(O)(CC(O)=O)C(O)=O,"""InChI=1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)""",N/A,1,Positive,GNPS-MSMLS,215.016,UPDATE-SINGLE-ANNOTATED-GOLD,Gold,,C6H8O7,KRKNYBCHXYNGOX-UHFFFAOYSA-N,KRKNYBCHXYNGOX,Organic acids and derivatives,Carboxylic acids and derivatives,Tricarboxylic acids and derivatives,Fatty Acids and Conjugates,Hydroxy fatty acids,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005464401,citric acid,citric acid,Food|Medical,no_match,NA,NA,coagulation factor inhibitor,KRKNYBCHXYNGOX-UHFFFAOYSA-N,O=C(O)CC(O)(CC(=O)O)C(=O)O
31,CCMSLIB00005735276,12950,spectra_filtered.mgf,MASSBANK.mgf,0.964594,185330000,0,0.789832,16,0.000396729,502.295,1,temp/spectra_filtered.mgf12950,1,Massbank:EQ301903 Fexofenadine|2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidinyl]butyl]phenyl]-2-methylpropanoic acid,ESI,Hybrid FT,Isolated,Massbank,Massbank,M+H,502.295,0,1,83799-24-0,N/A,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,"1S/C32H39NO4/c1-31(2,30(35)36)25-17-15-24(16-18-25)29(34)14-9-21-33-22-19-28(20-23-33)32(37,26-10-5-3-6-11-26)27-12-7-4-8-13-27/h3-8,10-13,15-18,28-29,34,37H,9,14,19-23H2,1-2H3,(H,35,36)",N/A,3,Positive,MASSBANK,502.295,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C32H39NO4,RWTNPBWLLIMQHL-UHFFFAOYSA-N,RWTNPBWLLIMQHL,Benzenoids,Benzene and substituted derivatives,Diphenylmethanes,,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005735276,fexofenadine,fexofenadine,Medical,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,RWTNPBWLLIMQHL-UHFFFAOYSA-N,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1
32,CCMSLIB00005755186,7667,spectra_filtered.mgf,MASSBANK.mgf,0.930128,42840000,0,2.19384,6,0.000610352,278.212,1,temp/spectra_filtered.mgf7667,1,Massbank:TUE00812 Venlafaxine,ESI,qTof,Isolated,Massbank,Massbank,M+H,278.211,0,1,N/A,N/A,CN(C)CC(c1ccc(cc1)OC)C2(CCCCC2)O,"1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3",N/A,3,Positive,MASSBANK,278.211,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C17H27NO2,PNVNVHUZROJLTJ-UHFFFAOYSA-N,PNVNVHUZROJLTJ,Benzenoids,Phenol ethers,Anisoles,,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005755186,venlafaxine,venlafaxine,Medical,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,PNVNVHUZROJLTJ-UHFFFAOYSA-N,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1
33,CCMSLIB00005766124,5174,spectra_filtered.mgf,MASSBANK.mgf,0.985914,302260000,0,1.01679,5,0.000198364,195.088,1,temp/spectra_filtered.mgf5174,1,"Massbank:LU119903 Caffeine|1,3,7-trimethylpurine-2,6-dione",ESI,Hybrid FT,Isolated,Massbank,Massbank,M+H,195.088,0,1,58-08-2,N/A,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,"1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",N/A,3,Positive,MASSBANK,195.088,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C8H10N4O2,RYYVLZVUVIJVGH-UHFFFAOYSA-N,RYYVLZVUVIJVGH,Organoheterocyclic compounds,Imidazopyrimidines,Purines and purine derivatives,Pseudoalkaloids,Purine alkaloids,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005766124,caffeine,caffeine,Food|Medical,central nervous system stimulant|methylxanthine,neurology/psychiatry|pulmonary,fatigue|drowsiness|apné,adenosine receptor antagonist|phosphodiesterase inhibitor,RYYVLZVUVIJVGH-UHFFFAOYSA-N,Cn1c(=O)c2c(ncn2C)n(C)c1=O
34,CCMSLIB00006377656,9461,spectra_filtered.mgf,BMDMS-NP.mgf,0.933361,75430000,0,0,14,0,303.05,1,temp/spectra_filtered.mgf9461,1,Quercetin,ESI,Orbitrap,Commercial standard,BMDMS-NP,BMDMS-NP,[M+H]+,303.05,302.043,1,N/A,N/A,O=C1C(O)=C(OC=2C=C(O)C=C(O)C12)C=3C=CC(O)=C(O)C3,"InChI=1S/C15H10O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,16-19,21H",N/A,1,Positive,BMDMS-NP,303.05,UPDATE-SINGLE-ANNOTATED-GOLD,Gold,,C15H10O7,REFJWTPEDVJJIY-UHFFFAOYSA-N,REFJWTPEDVJJIY,Phenylpropanoids and polyketides,Flavonoids,Flavones,Flavonoids,Flavonols,Shikimates and Phenylpropanoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00006377656,quercetin,quercetin,Food|Medical,dietary supplement,NA,NA,polar auxin transport inhibitor,REFJWTPEDVJJIY-UHFFFAOYSA-N,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12
35,CCMSLIB00006565425,12688,spectra_filtered.mgf,GNPS-LIBRARY.mgf,0.836545,664300000,0,1.34433,15,0.000488281,363.216,1,temp/spectra_filtered.mgf12688,1,Cortisol,LC-ESI,qTof,Commercial,Aldo Moreno Ulloa,Aldo Moreno Ulloa,M+H,363.216,362.209,1,50-23-7,5754,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O,"1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1", ,3,Positive,GNPS-LIBRARY,363.216,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C21H30O5,JYGXADMDTFJGBT-VWUMJDOOSA-N,JYGXADMDTFJGBT,Lipids and lipid-like molecules,Steroids and steroid derivatives,Hydroxysteroids,Steroids,Pregnane steroids,Terpenoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00006565425,hydrocortisone,hydrocortisone,Endogenous|Medical,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,JYGXADMDTFJGBT-VWUMJDOOSA-N,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO
36,CCMSLIB00006679126,4698,spectra_filtered.mgf,MONA.mgf,0.835275,2.018e+09,0,1.20154,3,0.000198364,165.091,1,temp/spectra_filtered.mgf4698,1,ISOEUGENOL,ESI,Orbitrap,isolated,MoNA,MoNA:MoNA038797,M+H,165.091,0,1,N/A,N/A,C/C=C/C1=CC=C(C(=C1)OC)O,"""InChI=1S/C10H12O2/c1-3-4-8-5-6-9(11)10(7-8)12-2/h3-7,11H,1-2H3/b4-3+""",N/A,3,positive,MONA,165.091,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H12O2,BJIOGJUNALELMI-ONEGZZNKSA-N,BJIOGJUNALELMI,Benzenoids,Phenols,Methoxyphenols,Phenylpropanoids (C6-C3),Cinnamic acids and derivatives,Shikimates and Phenylpropanoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00006679126,isoeugenol,isoeugenol,Medical,no_match,no_match,no_match,no_match,BJIOGJUN/ALELMI-ONEGZZNKSA-N,CC=Cc1ccc(O)c(OC)c1
37,CCMSLIB00006679126,5214,spectra_filtered.mgf,MONA.mgf,0.821524,1164100000,0,1.20154,3,0.000198364,165.091,1,temp/spectra_filtered.mgf5214,1,ISOEUGENOL,ESI,Orbitrap,isolated,MoNA,MoNA:MoNA038797,M+H,165.091,0,1,N/A,N/A,C/C=C/C1=CC=C(C(=C1)OC)O,"""InChI=1S/C10H12O2/c1-3-4-8-5-6-9(11)10(7-8)12-2/h3-7,11H,1-2H3/b4-3+""",N/A,3,positive,MONA,165.091,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H12O2,BJIOGJUNALELMI-ONEGZZNKSA-N,BJIOGJUNALELMI,Benzenoids,Phenols,Methoxyphenols,Phenylpropanoids (C6-C3),Cinnamic acids and derivatives,Shikimates and Phenylpropanoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00006679126,isoeugenol,isoeugenol,Medical,no_match,no_match,no_match,no_match,BJIOGJUN/ALELMI-ONEGZZNKSA-N,CC=Cc1ccc(O)c(OC)c1
38,CCMSLIB00006679126,5909,spectra_filtered.mgf,MONA.mgf,0.830453,1.88e+09,0,1.20154,3,0.000198364,165.091,1,temp/spectra_filtered.mgf5909,1,ISOEUGENOL,ESI,Orbitrap,isolated,MoNA,MoNA:MoNA038797,M+H,165.091,0,1,N/A,N/A,C/C=C/C1=CC=C(C(=C1)OC)O,"""InChI=1S/C10H12O2/c1-3-4-8-5-6-9(11)10(7-8)12-2/h3-7,11H,1-2H3/b4-3+""",N/A,3,positive,MONA,165.091,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H12O2,BJIOGJUNALELMI-ONEGZZNKSA-N,BJIOGJUNALELMI,N/A,N/A,N/A,Phenylpropanoids (C6-C3),Cinnamic acids and derivatives,Shikimates and Phenylpropanoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00006679126,isoeugenol,isoeugenol,Medical,no_match,no_match,no_match,no_match,BJIOGJUN/ALELMI-ONEGZZNKSA-N,CC=Cc1ccc(O)c(OC)c1
39,CCMSLIB00010112940,30136,spectra_filtered.mgf,BERKELEY-LAB.mgf,0.856538,133400000,0,7.96057,10,0.00180054,226.18,1,temp/spectra_filtered.mgf30136,1,VITAMIN K1 CollisionEnergy:102040,LC-ESI,Orbitrap,Commercial,Trent Northen,JGI,M+2H],226.182,0,1,N/A,N/A,CC(=CCC1=C(C)C(=O)c2ccccc2C1=O)CCCC(C)CCCC(C)CCCC(C)C,"""InChI=1S/C31H46O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,18-20,22-24H,9-17,21H2,1-6H3/b25-20+""",N/A,3,Positive,BERKELEY-LAB,226.182,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C31H46O2,MBWXNTAXLNYFJB-UHFFFAOYSA-N,MBWXNTAXLNYFJB,Lipids and lipid-like molecules,Prenol lipids,Quinone and hydroquinone lipids,Meroterpenoids,Prenyl quinone meroterpenoids,Terpenoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010112940,phytomenadione,phytomenadione,Food|Medical,warfarin reversal agent|vitamin K replacement,hematology,vitamin K deficiency|anticoagulation reversal,vitamin K,MBWXNTAXLNYFJB-NKFFZRIASA-N,CC(C=Cc1c(C)c(O)c2ccccc2c1O)=CCCC(C)CCCC(C)CCCC(C)C
40,CCMSLIB00010114511,29788,spectra_filtered.mgf,BERKELEY-LAB.mgf,0.882018,46210000,0,5.17164,16,0.0032959,637.305,1,temp/spectra_filtered.mgf29788,1,AC1L1X1Z CollisionEnergy:102040,LC-ESI,Orbitrap,Commercial,Trent Northen,JGI,M+Na,637.302,0,1,N/A,N/A,NCC1OC(OC2C(CO)OC(OC3C(O)C(N)CC(N)C3OC3OC(CN)C(O)C(O)C3N)C2O)C(N)C(O)C1O,"""InChI=1S/C23H46N6O13/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22/h5-23,30-36H,1-4,24-29H2/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22?,23+/m1/s1""",N/A,3,Positive,BERKELEY-LAB,637.302,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C23H46N6O13,PGBHMTALBVVCIT-UHFFFAOYSA-N,PGBHMTALBVVCIT,Organic oxygen compounds,Organooxygen compounds,Carbohydrates and carbohydrate conjugates,Polyols,Amino cyclitols,Carbohydrates,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010114511,framycetin,framycetin,Medical,aminoglycoside antibacterial,infectious disease,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections,bacterial 30S ribosomal subunit inhibitor,PGBHMTALBVVCIT-UHFFFAOYSA-N,NCC1OC(OC2C(CO)OC(OC3C(O)C(N)CC(N)C3OC3OC(CN)C(O)C(O)C3N)C2O)C(N)C(O)C1O
41,CCMSLIB00010122114,18893,spectra_filtered.mgf,BERKELEY-LAB.mgf,0.875449,244600000,0,2.00453,9,0.00050354,251.201,1,temp/spectra_filtered.mgf18893,1,Sclareolide CollisionEnergy:205060,LC-ESI,Orbitrap,Commercial,Trent Northen,JGI,M+H,251.201,0,1,N/A,N/A,CC1(C)CCCC2(C)C1CCC1(C)OC(=O)CC12,"""InChI=1S/C16H26O2/c1-14(2)7-5-8-15(3)11(14)6-9-16(4)12(15)10-13(17)18-16/h11-12H,5-10H2,1-4H3/t11-,12+,15-,16+/m0/s1""",N/A,3,Positive,BERKELEY-LAB,251.201,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C16H26O2,IMKJGXCIJJXALX-UHFFFAOYSA-N,IMKJGXCIJJXALX,N/A,N/A,N/A,Diterpenoids,Norlabdane diterpenoids,Terpenoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010122114,sclareolide,sclareolide,Medical,no_match,NA,NA,other antifungal,IMKJGXCIJJXALX-SHUKQUCYSA-N,CC1(C)CCCC2(C)C1CCC1(C)OC(=O)CC12
42,CCMSLIB00010124262,14997,spectra_filtered.mgf,BERKELEY-LAB.mgf,0.732302,33960000,0,8.43281,8,0.00190735,226.18,1,temp/spectra_filtered.mgf14997,1,VITAMIN K1 CollisionEnergy:205060,LC-ESI,Orbitrap,Commercial,Trent Northen,JGI,M+2H],226.182,0,1,N/A,N/A,CC(=CCC1=C(C)C(=O)c2ccccc2C1=O)CCCC(C)CCCC(C)CCCC(C)C,"""InChI=1S/C31H46O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,18-20,22-24H,9-17,21H2,1-6H3/b25-20+""",N/A,3,Positive,BERKELEY-LAB,226.182,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C31H46O2,MBWXNTAXLNYFJB-UHFFFAOYSA-N,MBWXNTAXLNYFJB,Lipids and lipid-like molecules,Prenol lipids,Quinone and hydroquinone lipids,Meroterpenoids,Prenyl quinone meroterpenoids,Terpenoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010124262,phytomenadione,phytomenadione,Food|Medical,warfarin reversal agent|vitamin K replacement,hematology,vitamin K deficiency|anticoagulation reversal,vitamin K,MBWXNTAXLNYFJB-NKFFZRIASA-N,CC(C=Cc1c(C)c(O)c2ccccc2c1O)=CCCC(C)CCCC(C)CCCC(C)C
43,CCMSLIB00010131160,13028,spectra_filtered.mgf,MCE-DRUG.mgf,0.869537,14860000,0,1.65842,7,0.000854492,515.245,1,temp/spectra_filtered.mgf13028,1,Telmisartan,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,515.244,514.237,1,N/A,N/A,CCCc1nc2c(cc(-c3nc4ccccc4n3C)cc2C)n1Cc1ccc(-c2ccccc2C(=O)O)cc1,"""InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)""",RMMXLENWKUUMAY-UHFFFAOYSA-N,3,Positive,MCE-DRUG,515.244,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C33H30N4O2,RMMXLENWKUUMAY-UHFFFAOYSA-N,RMMXLENWKUUMAY,Benzenoids,Benzene and substituted derivatives,Biphenyls and derivatives,Anthranilic acid alkaloids,Phenazine alkaloids,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010131160,telmisartan ,telmisartan ,Medical,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,RMMXLENWKUUMAY-UHFFFAOYSA-N,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1
44,CCMSLIB00010147596,8371,spectra_filtered.mgf,MCE-DRUG.mgf,0.982703,28240000,0,1.34315,9,0.000518799,386.254,1,temp/spectra_filtered.mgf8371,1,buspirone,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,386.255,385.248,1,N/A,N/A,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,"""InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2""",QWCRAEMEVRGPNT-UHFFFAOYSA-N,3,Positive,MCE-DRUG,386.255,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C21H31N5O2,QWCRAEMEVRGPNT-UHFFFAOYSA-N,QWCRAEMEVRGPNT,Organoheterocyclic compounds,Diazinanes,Piperazines,Lysine alkaloids,Quinolizidine alkaloids,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010147596,buspirone ,buspirone ,Medical,anxiolytics,neurology/psychiatry,generalized anxiety disorder (GAD),serotonin receptor agonist,QWCRAEMEVRGPNT-UHFFFAOYSA-N,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
